Sinochem International Corporation (600500.SS) Bundle
Investors eyeing Sinochem International Corporation will want to dig into a mixed picture: trailing twelve‑month revenue sits at 49.15 billion CNY (down 3.15% TTM and from fiscal 2024's 52.93 billion CNY), contrasting with a previous 2022 high of 87.45 billion CNY, while profitability shows strain with a reported net loss of -2.947 billion CNY (TTM), a profit margin of -5.66%, EPS of -0.82 CNY and ROE (TTM) of -16.53%; balance sheet metrics reveal total assets of 42.56 billion CNY versus liabilities of 38.99 billion CNY and a debt‑to‑equity ratio near 0.91, supported by cash and equivalents of 6.076 billion CNY but a low cash ratio of 0.15; valuation paints a nuanced story with market cap around 13.7-13.85 billion CNY, a trailing P/E of 82.67 and forward P/E of 11.35, plus a P/S of 0.27, while strategic moves - including a planned 100% acquisition of Nantong Xingchen (projected to add >2.3 billion CNY revenue H1 2025) and procurement agreements worth US$14.4 billion secured at CIIE 2025 - point to potential upside amid liquidity and leverage considerations.
Sinochem International Corporation (600500.SS) - Revenue Analysis
Sinochem International Corporation's top-line performance has weakened over the recent period, with revenue compression visible across fiscal 2022-2025 (TTM). Key numeric highlights and contextual figures are summarized below.- Total revenue (TTM ending Sep 30, 2025): 49.15 billion CNY (‑3.15% YoY).
- Revenue (FY 2024): 52.93 billion CNY (‑2.48% vs. 2023).
- Revenue (FY 2022): 87.45 billion CNY - material base year now followed by significant declines in 2023 and 2024.
- Revenue per employee: 5.09 million CNY; total employees: 9,649.
- Market capitalization (as of Dec 16, 2025): ≈13.73 billion CNY.
| Period | Revenue (billion CNY) | YoY % change | Notes |
|---|---|---|---|
| Trailing 12 months (ending 2025-09-30) | 49.15 | ‑3.15% | Most recent TTM figure showing continued contraction |
| FY 2024 | 52.93 | ‑2.48% | Moderate decline from 2023 levels |
| FY 2023 | 54.29 | Data implied (derived from FY 2024 decline) | Step down from 2022 peak |
| FY 2022 | 87.45 | - | Highest reported in the recent multi‑year window |
| Employees | 9,649 | - | Revenue per employee: 5.09 million CNY |
| Market capitalization (2025-12-16) | 13.73 (billion CNY) | - | Market value relative to trailing revenue indicates valuation metrics to monitor |
- Pattern: sharp drop from 87.45 bn CNY (2022) to the low‑50s in 2023-2024, continuing to ~49.15 bn CNY TTM 2025.
- Implication: pressure on margin recovery and need for revenue drivers or cost offsets to restore historical scale.
- Investor focus areas: sales mix, commodity exposure, asset rotations, and workforce productivity given 5.09 mn CNY revenue per employee.
Sinochem International Corporation (600500.SS) - Profitability Metrics
Sinochem International's most recent trailing twelve months (TTM) results through March 31, 2025 show material negative profitability, driven by operating losses and strained returns for shareholders and assets. Key headline figures are summarized below.- Net loss (TTM): -2,947 million CNY
- Operating margin: -2.49%
- Profit margin: -5.66%
- Return on assets (ROA, TTM): -2.27%
- Return on equity (ROE, TTM): -16.53%
- Earnings per share (EPS, TTM): -0.82 CNY
| Metric | Value (TTM) | Interpretation |
|---|---|---|
| Net Income | -2,947 million CNY | Loss position reduces retained earnings and equity cushion |
| Operating Margin | -2.49% | Core operations failing to generate positive margin |
| Profit Margin | -5.66% | After-tax losses exceed revenues on a percentage basis |
| ROA | -2.27% | Assets are generating negative returns |
| ROE | -16.53% | Equity holders experiencing large negative returns |
| EPS | -0.82 CNY | Negative per-share earnings reflect sustained losses |
- Reduce operating expenses and improve gross-to-operating conversion to move operating margin toward break-even.
- Divest or restructure underperforming assets to limit negative ROA drag.
- Re-evaluate pricing, procurement, and supply-chain efficiencies to lift profit margin.
- Prioritize high-return investments and limit equity dilution to stabilize ROE and EPS.
Sinochem International Corporation (600500.SS) - Debt vs. Equity Structure
Sinochem International's balance-sheet position as of March 31, 2025 shows a capital structure tilted toward liabilities but supported by a tangible equity base. Key headline figures and interpretations are presented below.- Total assets: 42.56 billion CNY
- Total liabilities: 38.99 billion CNY
- Total equity: 3.57 billion CNY
| Metric | Value (CNY) | Notes |
|---|---|---|
| Total assets | 42.56 billion | Aggregate resources available to the company |
| Total liabilities | 38.99 billion | Includes short- and long-term obligations |
| Total equity | 3.57 billion | Shareholders' residual interest |
| Debt-to-equity ratio | 0.91 | Calculated as liabilities / equity (≈38.99 / 3.57) |
- The debt-to-equity ratio of approximately 0.91 indicates notable financial leverage - liabilities are nearly on par with equity adjusted for scale.
- Equity of 3.57 billion CNY provides a buffer, but the relatively high ratio suggests the company relies meaningfully on debt financing.
- Debt levels are currently manageable given total assets of 42.56 billion CNY, yet they warrant continued monitoring for liquidity and refinancing risk.
- Overall financial structure appears balanced with a slight inclination toward debt, reflecting moderate leverage without extreme overextension.
Sinochem International Corporation (600500.SS) - Liquidity and Solvency
Sinochem International's short-term liquidity profile shows mixed signals: the current ratio of 1.25 implies adequate coverage of current liabilities by current assets, but the quick ratio of 0.95 and a cash ratio of 0.15 indicate limited immediate liquid resources without relying on inventory or other non-cash current assets. On the solvency side, a solvency ratio of 0.85 points to a capital structure with a high proportion of assets financed through debt, increasing financial leverage and interest burden risk.| Metric | Value | Implication |
|---|---|---|
| Current Ratio | 1.25 | Adequate short-term asset coverage of liabilities |
| Quick Ratio | 0.95 | Potential difficulty meeting obligations without selling inventory |
| Cash & Cash Equivalents | 6.076 billion CNY | Reasonable operational buffer |
| Cash Ratio | 0.15 | Low ability to cover short-term liabilities with cash alone |
| Solvency Ratio | 0.85 | High leverage; significant assets financed by debt |
- Operational liquidity: current ratio (1.25) and cash (6.076B CNY) provide short-term stability for working capital cycles.
- Immediate liquidity risk: quick ratio (0.95) and cash ratio (0.15) suggest reliance on inventory liquidation or receivables collection to meet near-term obligations.
- Leverage considerations: solvency ratio (0.85) signals material debt exposure-interest rate movements or tightened credit could pressure cash flows.
Sinochem International Corporation (600500.SS) - Valuation Analysis
As of July 1, 2025, key market-value and valuation metrics for Sinochem International Corporation (600500.SS) present a mixed signal: market cap is modest, price-based multiples show divergence between earnings and sales perspectives, and enterprise-value measures imply a conservative take relative to revenue.| Metric | Value | Interpretation |
|---|---|---|
| Market Capitalization | 13.85 billion CNY | Size reference for equity-market value |
| Trailing P/E | 82.67 | High valuation relative to past earnings |
| Forward P/E | 11.35 | Market expects significant earnings improvement |
| Price-to-Sales (P/S) | 0.27 | Low valuation relative to revenue |
| Enterprise Value / Revenue (EV/Revenue) | 0.76 | Enterprise-level valuation modest vs. sales |
- Discrepancy between trailing P/E (82.67) and forward P/E (11.35) signals either recent earnings weakness, one-off items in the trailing period, or substantial analyst/market expectations for near-term profit recovery.
- Low P/S (0.27) and EV/Revenue (0.76) indicate the market prices the company conservatively on a revenue basis-useful for asset- or sales-backed valuation comparisons.
- High trailing P/E increases sensitivity to any earnings misses; forward P/E implies vulnerability to forecast revisions.
- Relative to peers in chemicals/trading and agribusiness segments, a P/S of 0.27 suggests potential undervaluation on sales multiples but must be reconciled with profitability metrics.
- Forward P/E of 11.35 may reflect anticipated margin expansion, asset disposals, non-recurring recovery, or analyst optimism-validate by checking projected EPS drivers and management guidance.
- EV/Revenue at 0.76 is compatible with cyclical businesses where revenue is large but margins vary; assess EBITDA margins, capex needs, and working-capital dynamics to convert revenue into free cash flow.
- Recent trailing twelve months (TTM) EPS and any non-recurring items that inflated the trailing P/E.
- Analyst consensus EPS for the next 12 months underpinning the forward P/E of 11.35.
- Revenue quality (recurring vs. transactional), gross and EBITDA margins, and working-capital trends supporting the low P/S and EV/Revenue.
Sinochem International Corporation (600500.SS) Risk Factors
Sinochem International Corporation (600500.SS) faces several identifiable financial and operational risks that investors should weigh carefully. Recent performance and balance-sheet metrics indicate strains in profitability, liquidity and reliance on debt financing that can amplify downside in adverse market conditions.- Net loss: Trailing twelve months (TTM) net loss of -2.947 billion CNY (ending March 31, 2025), signaling operational issues or one-off items that eroded earnings.
- Profitability pressure: Negative profit margin of -5.66% reflects that core operations are not generating positive returns on sales.
- Valuation risk: Trailing P/E of 82.67 implies high market expectations; if earnings fail to recover, the stock could face sharp re-rating.
- Quick ratio of 0.95 - below 1.0, suggesting the company may struggle to cover immediate liabilities without converting inventory to cash.
- Debt profile: Debt-to-equity ratio of 0.91 indicates moderate leverage; manageable in stable conditions but risky if cash flows deteriorate.
- Solvency concerns: Solvency ratio of 0.85 highlights dependence on external financing and exposure to rising interest rates or refinancing stress.
| Metric | Value | Implication |
|---|---|---|
| Net Income (TTM) | -2.947 billion CNY | Operating losses reduce equity and limit reinvestment capacity |
| Profit Margin | -5.66% | Negative margins point to unprofitable core operations |
| Trailing P/E | 82.67 | High valuation vs. current earnings - downside if growth disappoints |
| Debt-to-Equity | 0.91 | Moderate leverage that increases financial risk |
| Quick Ratio | 0.95 | Potential near-term liquidity squeeze without inventory sales |
| Solvency Ratio | 0.85 | Reliance on debt financing; sensitive to interest rate moves |
Sinochem International Corporation (600500.SS) - Growth Opportunities
Sinochem International is positioning for accelerated top-line expansion through strategic acquisitions, global procurement partnerships, and sector diversification. Key near-term catalysts and their quantifiable impacts:- Planned acquisition of 100% equity in Nantong Xingchen Synthetic Materials Co., Ltd.-management projects this could increase revenue by over 2.3 billion CNY in H1 2025, adding specialty chemical revenues and higher-margin product lines.
- Participation in the 8th China International Import Expo (CIIE) in November 2025 yielded procurement agreements totaling US$14.4 billion, strengthening global sourcing and distribution capacity.
- Sinochem Holdings secured procurement agreements with nearly 20 enterprises across more than 10 countries/regions (Saudi Arabia, Oman, Kazakhstan, France, Japan, South Korea, Belgium, Malaysia, Mozambique, Thailand, etc.), supporting market diversification and supply-chain resilience.
- Strategic focus areas-crude oil & petroleum products, food & agricultural products, chemicals, chemical equipment, and trade services-offer multiple sectoral levers for growth and cross-selling synergies.
- Acquiring Nantong Xingchen, described as a "hidden champion" in new chemical materials, can broaden the company's product portfolio and improve positioning in specialty and high-value chemical markets.
- Ongoing initiatives to deepen cooperation within China aim to capture domestic demand and integrate local upstream/downstream assets for margin enhancement.
| Growth Driver | Quantified Impact / Scale | Timing | Strategic Benefit |
|---|---|---|---|
| Nantong Xingchen acquisition | +>2.3 billion CNY revenue (H1 2025) | Closed in 2024-2025 (planned) | Specialty chemicals, margin uplift, product portfolio expansion |
| CIIE procurement agreements | US$14.4 billion total procurement (Nov 2025) | Announced Nov 2025 | Global supply expansion, strengthened procurement pipeline |
| Sinochem Holdings procurement partners | ~20 enterprises; >10 countries/regions | Ongoing 2024-2025 | Market diversification, supply-chain resilience |
| Sector focus - energy, agriculture, chemicals, equipment, services | Revenue exposure across multiple high-demand industries | Ongoing | Cross-sector synergies, risk dispersion |
| Domestic cooperation initiatives | Scale and integration potential within Chinese market (qualitative) | Ongoing | Capture domestic demand, operational integration |
- Near-term revenue sensitivity: successful integration of Nantong Xingchen is critical to realize the >2.3 billion CNY incremental revenue; failure or delays would materially affect the 2025 outlook.
- Currency and commodity exposure: US$14.4 billion in procurement expands foreign-denominated activity-FX management and commodity price hedging will be important to protect margins.
- Geographic diversification: procurement links across the Middle East, Central Asia, Europe, and Asia reduce single-market risk but require trade, logistics, and regulatory coordination.
Sinochem International Corporation (600500.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.